Showing results (2361-2370 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 27, 2014
Bioinformatics for cancer immunotherapy target discoveryLars Rønn Olsen, Benito Campos, Mike Stein Barnkob, et al.Cancer Immunology, Immunotherapy : CII|October 30, 2014
N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cellsXiaofeng Wang, Andrew Breeze, Marianna KulkaCancer Immunology, Immunotherapy : CII|November 14, 2014
Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigmLarry A Harshyne, Kirsten M Hooper, Edward G Andrews, et al.Cancer Immunology, Immunotherapy : CII|October 17, 2014
Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levelsPia Vihinen, Taina Tervahartiala, Timo Sorsa, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Hairy cell sensitivity to the lysis in vitro. Role of the anti-CD3 antibody in generating a susceptibility to the lysisG Semenzato, L Trentin, R Zambello, et al.Cancer Immunology, Immunotherapy : CII|February 9, 2000
gammadelta T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysisM L Thomas, U C Samant, R K Deshpande, et al.Cancer Immunology, Immunotherapy : CII|April 24, 2001
Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cellsE C Shin, W C Shin, Y Choi, et al.Cancer Immunology, Immunotherapy : CII|April 24, 2001
The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cellsS Y Chong, M Zhang, Y C Lin, et al.Cancer Immunology, Immunotherapy : CII|April 15, 1999
Rejection of tumors of the B cell lineage by idiotype-vaccinated miceJ Haimovich, T Kukulansky, B Weissman, et al.Cancer Immunology, Immunotherapy : CII|April 15, 1999
Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasisA M Watts, M H Shearer, H I Pass, et al.Pageof 652